Recombinant Rat MAG/Siglec-4a Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 538-MG
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Rat MAG (Gly20-Pro516) Accession # P07722 |
DIEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
Able to significantly inhibit neurite outgrowth when immobilized as a 3 µL droplet containing 400 ng on a nitrocellulose-coated microplate.
Reviewed Applications
Read 1 review rated 4 using 538-MG in the following applications:
Formulation, Preparation and Storage
538-MG
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 250 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: MAG/Siglec-4a
MAG (Myelin-Associated Glycoprotein), a type I transmembrane glycoprotein containing five Ig-like domains in its extracellular domain is an adhesion molecule belonging to the immunoglobin superfamily. Within this superfamily, MAG, CD22, CD33, Schwann cell myelin protein, and sialoadhesin which bind specifically to cell-surface glycan containing sialic acid residues define the I-type sialyl lectin subgroup, also called the sialoadhesin family. Sialoadhesins mediate diverse biological processes through recognition of specific sialyted glycans on cell surface. MAG is expressed on myelinating oligodenrocytes and Schwann cells, and preferentially recognizes alpha2, 3-linked sialic acid on O-linked glycans and gangliosides. MAG exists as two isoforms which differ in the sequence and length of the cytoplasmic tail. The large form (71 kDa) and small form (67 kDa) arise from alternative spliced mRNAs. Although MAG might encounter haematopoietic cells and lymphocytes under pathologic conditions, it would normally be expected to interact with neuronal cells. It has been shown that MAG promotes axonal growth from neonatal DRG neurons and embryonic spinal neurons, but is a potent inhibitor of axonal re-growth from adult DRG and postnatal cerebellar neurons. MAG plays an important role in the interaction between axons and myelin. A soluble form of MAG containing the extracellular domain is released from myelin in large quantities and identified in normal human tissues and in tissues from patients with neurological disorders. This soluble MAG might contribute to the lack of CNS neuron regeneration after injury.
References
- Kelm, S. et al. (1994) Current Biology 4:965.
- McKerracher, L. et al. (1994) Neuron 13:805.
- Tang, S. et al. (1997) Molecular and Cellular Neuroscience 9:333.
- Cai, D. et al. (1999) Neuron 22:89.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional MAG/Siglec-4a Products
Product Documents for Recombinant Rat MAG/Siglec-4a Fc Chimera Protein, CF
Product Specific Notices for Recombinant Rat MAG/Siglec-4a Fc Chimera Protein, CF
For research use only